New insider activity at DENTSPLY SIRONA ( (XRAY) ) has taken place on March 4, 2025.
Director Gregory Lucier has made a significant investment in DENTSPLY SIRONA by purchasing 15,142 shares of the company’s stock, with the transaction valued at $249,994.
Recent Updates on XRAY stock
DENTSPLY SIRONA’s recent earnings call revealed a mixed outlook with growth in segments like Europe and imaging, but significant challenges in the Byte segment and U.S. sales decline. The Byte business faced a $62 million impact due to customer refunds and sales suspension, contributing to a cautious 2025 outlook. Analysts have lowered price targets due to these challenges, with Barrington citing the Byte aligner business shutdown as a major factor for revenue decline. Baird noted some progress but emphasized the need for further improvement. Wells Fargo highlighted the Q4 shortfall and macroeconomic caution, while BofA pointed to softer organic growth affecting valuation. Despite these issues, strategic initiatives and board additions aim to navigate the current market landscape.
More about DENTSPLY SIRONA
YTD Price Performance: -11.73%
Average Trading Volume: 2,655,908
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.29B